Necpal, Philipp
Kaiser, Klemens P.
Kroener, Ron C.
Singh, Pankaj
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 17 March 2026
Accepted: 18 April 2026
First Online: 26 April 2026
Declarations
:
: The study was approved by the Ethics Committee of Goethe University Frankfurt (approval number 2025–2683). Due to the retrospective nature of the study, informed consent to participate was not required in accordance with applicable national regulations. The study adhered to the tenets of the Declaration of Helsinki.
: Not applicable.
: K.P.K: Lecture fees from Oculus. He received an ESCRS Peter Barry Fellowship Grant. P.S: Lecturing for AbbVie, Alimera, Bayer, Novartis, and Roche. Consultant for Roche. P.N. and R.K. have no financial or non-financial conflicts of interest to declare.